FDA Did Not Seek Plan B “Minority Opinion,” Crawford Tells Subcommittee
This article was originally published in The Tan Sheet
FDA never asked for or received a memo from former Reproductive Health Drugs Advisory Committee member David Hager, MD, outlining a "minority opinion" on the possible Rx-to-OTC switch of Plan B, Commissioner Lester Crawford stated July 26
You may also be interested in...
The House Appropriations/Agriculture Subcommittee voted May 17 to withhold 5% of the funds for FDA's central offices until Acting Commissioner Lester Crawford testifies before the committee on the President's FY 2006 budget request
FDA Acting Commissioner Lester Crawford's bid for the permanent post has been cast further into doubt by a Republican joining the list of Senators threatening holds on his nomination
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC